Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,020.00    -110.00 (-1.54%)
Bid:
7,010.00
Ask:
7,020.00
Spread: 10.00 (0.143%)
Market Cap: £9.41b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Second Interim Management Statement

6 Aug 2009 07:00

RNS Number : 9498W
Diploma PLC
06 August 2009
 



12 CHARTERHOUSE SQUARE, LONDON EC1M 6AXTELEPHONE: +44 (0)20 7549 5700FACSIMILE: +44 (0)20 7549 5715

FOR IMMEDIATE RELEASE

6 August 2009

DIPLOMA PLC

SECOND INTERIM MANAGEMENT STATEMENT

IN RESPECT OF YEAR ENDING 30 SEPTEMBER 2009

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing its second Interim Management Statement which relates to the period from 1 April 2009 to date.

Trading

The Group has continued to demonstrate its resilient characteristics in the face of the weak trading environment. Revenues for the year to date, in UK sterling, are 1% above the comparable period last year, reflecting similar trends to those reported in the first half of the year. The Group continued to benefit from the contributions from the businesses acquired during the year and from the positive impact, on the translation of the results of overseas businesses, of a weaker UK sterling against the comparable period in 2008. Adjusting for currency effects and acquisitions, revenues for the year to date have decreased by 12%.

In the Life Sciences sector, year to date revenues are 4% ahead of the prior year comparable period, with growth driven principally by the strong performances in the Canadian Healthcare businesses. Revenues from the European businesses continued to be affected by customers delaying capital expenditure, but operating margins are now benefiting from earlier cost reduction initiatives.

The Seals sector businesses continued to face difficult trading conditions, though with some signs of stability now appearing in the core North American businesses. The European seals businesses have been impacted by the downturn in industrial activity in Continental Europe, but trading conditions in the aftermarket sector have stabilised. Operating margins, though still lower than the prior year, are benefiting from cost reductions initiated earlier in the year in the North American businesses and more recently in Europe. Year to date sector revenues in UK sterling terms remain 16% ahead of last year, but have benefited strongly from currency translation and the acquisition of RTD Seals.

In the Controls sector, year to date revenues are 11% down on the prior year comparable period. The UK Controls businesses have continued to experience mixed trading conditions, with Military Aerospace and Defence markets benefiting from ongoing up-grade, refurbishment and maintenance programmes and Calibration services also performing well. However, demand in the Motorsport market has been softer and the general Commercial and Industrial business has been more exposed to the downturn in UK industrial markets. In Germany, the market downturn came later and there has been a greater impact on these businesses from reduced activity in major projects and export led business.

Financial Position

The Group's cash flow generation has continued to be strong, benefiting from the ongoing focus on working capital, with further reductions achieved in stock and debtor balances. As at 31 July 2009, the Group's net cash funds had increased to a level in excess of £12.0m, compared with £5.5m reported at 31 March 2009.

The Group continues to maintain a strong balance sheet, underpinned by a committed multi-currency facility of ca. £18m, which expires in November 2010.

There have been no other material changes in the position of the Group in the period since the publication of the Interim Report for the six months ended 31 March 2009.

Outlook

The Group's recent management results indicate that trading volumes in the Group's key geographic markets are broadly stable and that operating margins are benefiting from cost reduction programmes, commenced earlier in the financial year. The Board therefore remains confident of being able to report results for the year which are in line with current market expectations.

Over the longer term, the Board is satisfied that, with a reduced cost base, the Group is well positioned in its key markets to benefit strongly from a recovery in global economic conditions.

 

Notes:

1. This Interim Management Statement, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

2. The Group's results for the year ending 30 September 2009 are expected to be released in mid November 2009.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

 

NOTE TO EDITORS:

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

The Group employs ca. 1,000 employees and its principal operating businesses are located in the UKGermany, US and Canada.

In the last five years ended 30 September 2008, the Group has grown adjusted earnings per share at an average of ca. 21% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £160m.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDILUGGGCU
Date   Source Headline
16th Jan 202010:40 amRNSResult of AGM
15th Jan 20207:00 amRNSTrading Statement
24th Dec 20197:00 amRNSDirector / PDMR Grant of LTIP Award
23rd Dec 20197:00 amRNSDirectorate Change
17th Dec 20195:09 pmRNSHolding(s) in Company
16th Dec 201912:00 pmRNSHolding(s) in Company
6th Dec 20193:27 pmRNSAnnual Financial Report & Notice of AGM
21st Nov 20194:00 pmRNSDirector/PDMR Shareholding
18th Nov 20197:00 amRNSFinal Results
8th Oct 20197:00 amRNSDirectorate Change
25th Sep 20197:00 amRNSAcquisition
10th Sep 20194:49 pmRNSHolding(s) in Company
28th Aug 20197:00 amRNSTrading Statement
8th Aug 20193:00 pmRNSHolding(s) in Company
17th Jul 20191:01 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSAcquisition
13th Jun 20192:00 pmRNSDirector Declaration
13th May 20197:00 amRNSHalf-year Report
1st Apr 20197:00 amRNSAppointment of Joint Corporate Broker
27th Mar 20197:00 amRNSHalf Year Trading Update
26th Feb 20197:00 amRNSDirector/PDMR Shareholding
25th Feb 20194:00 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSDirectorate Appointments
29th Jan 20193:30 pmRNSDirector/PDMR Shareholding
16th Jan 20194:19 pmRNSResult of AGM
16th Jan 20197:01 amRNSDirectorate Change
16th Jan 20197:00 amRNSTrading Statement
7th Dec 20184:09 pmRNSDirector/PDMR Shareholding
7th Dec 20183:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20184:26 pmRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSFinal Results
12th Oct 20187:00 amRNSAcquisition
3rd Sep 20184:45 pmRNSBoard Committee Change
29th Aug 20187:01 amRNSDirectorate Change
29th Aug 20187:00 amRNSTrading Statement
22nd Aug 20187:00 amRNSAcquisition
10th Jul 20181:46 pmRNSHolding(s) in Company
12th Jun 20182:59 pmRNSHolding(s) in Company
16th May 20182:41 pmRNSDirector Declaration
15th May 20184:20 pmRNSDirector/PDMR Shareholding
15th May 20184:09 pmRNSDirector/PDMR Shareholding
14th May 20187:00 amRNSHalf-year Report
9th May 20187:00 amRNSDirectorate Change
23rd Apr 20187:00 amRNSDirectorate Change
28th Mar 20187:00 amRNSTrading Update
21st Mar 20189:30 amRNSHolding(s) in Company
20th Mar 20184:00 pmRNSHolding(s) in Company
6th Feb 20189:49 amRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSDirectorate Change
23rd Jan 20184:00 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.